United Kingdom · Seed startup
3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 2 months ago
Follow Magnitude Biosciences and see its new rounds in your feed. Start following
Funding summaryUpdated 7 Nov 2026
$4.0Mraised across 3 rounds since 2022, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by EU-Startups and 2 others
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
From Magnitude Biosciences's own website: 5 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Northstar VenturesL
Innovate UK
Maven Ventures
Finance Durham FundNPIF II – Maven Equity FinanceMissing a round, or an investor who was in one? Tell us.
Magnitude Biosciences's investors include Northstar Ventures, Innovate UK, Maven Ventures, Finance Durham Fund and NPIF II – Maven Equity Finance. Northstar Ventures led its latest round.
Magnitude Biosciences has raised $4.0M across 3 rounds since 2022.
Magnitude Biosciences's most recent round was a Seed of $1.8M in Sept 2026, led by Northstar Ventures.
Its most recent round, $1.8M in Sept 2026, is also its largest on record.
Magnitude Biosciences's first round on record, in May 2025, was backed by Innovate UK and Northstar Ventures.
Magnitude Biosciences's latest named round is a Seed, in Sept 2026.
Magnitude Biosciences is based in the United Kingdom.
Northstar Ventures led the Seed in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
